Options Brief: Keryx Biopharmaceuticals, Inc (KERX)
Shares of Keryx Biopharmaceuticals, Inc (NASDAQ: KERX) are higher on the session by 6.70%, trading at $4.62.
Overall call volume is now running at 2.31x the daily average, with 67% of all calls traded being purchases on the offer. 1,245 contracts have traded on the session so far.
Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.